| Farid Dahi, | |
|
801 Ostrum St, Bethlehem, PA 18015-1000 | |
| (484) 526-4000 | |
| (706) 653-1230 |
| Full Name | Farid Dahi |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 20 Years |
| Location | 801 Ostrum St, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215293436 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| St Luke's Hospital - Anderson Campus | Easton, PA | Hospital |
| St Luke's Warren Hospital | Phillipsburg, NJ | Hospital |
| St Lukes Quakertown Hospital | Quakertown, PA | Hospital |
| St Luke's Hospital - Monroe Campus | Stroudsburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Progressive Physician Assoc Inc | 1355243809 | 118 |
| Progressive Physician Assoc Inc | 1355243809 | 118 |
News Archive
SurgiCount Medical, the wholly-owned operating subsidiary of Patient Safety Technologies, Inc., today announced that it has signed a contract with Kalispell Regional Medical Center to implement the SurgiCount Safety-Sponge® System, a proven solution to prevent one of the most common surgical errors, retained surgical sponges.
Since the vast majority of Americans who have health coverage get it through their jobs, one obvious question raised by the health reform legislation pending in Congress is: How might it affect the U.S. employment-based health benefits system?
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today that the Company has entered into a sponsored research agreement and an option agreement with The University of Pennsylvania to support process development and manufacturing in a planned Phase II clinical trial of ICT-107, the Company's dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme.
Young adults who were born prematurely show multiple biological signs of risks to future health, research from Imperial College London has found. The scientists, reporting their findings tomorrow in the journal Pediatric Research, say that the research indicates that urgent work is now needed to monitor preterm babies into adulthood to improve the detection of early signs of disease.
HealthPartners Medical Group and Clinics and The Chartis Group today announce a unique collaboration to help hospitals and health systems achieve superior performance in health care quality and patient service, while simultaneously lowering costs.
› Verified 6 days ago
| Entity Name | Progressive Physician Assoc Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881646859 PECOS PAC ID: 1355243809 Enrollment ID: O20040123000977 |
News Archive
SurgiCount Medical, the wholly-owned operating subsidiary of Patient Safety Technologies, Inc., today announced that it has signed a contract with Kalispell Regional Medical Center to implement the SurgiCount Safety-Sponge® System, a proven solution to prevent one of the most common surgical errors, retained surgical sponges.
Since the vast majority of Americans who have health coverage get it through their jobs, one obvious question raised by the health reform legislation pending in Congress is: How might it affect the U.S. employment-based health benefits system?
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today that the Company has entered into a sponsored research agreement and an option agreement with The University of Pennsylvania to support process development and manufacturing in a planned Phase II clinical trial of ICT-107, the Company's dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme.
Young adults who were born prematurely show multiple biological signs of risks to future health, research from Imperial College London has found. The scientists, reporting their findings tomorrow in the journal Pediatric Research, say that the research indicates that urgent work is now needed to monitor preterm babies into adulthood to improve the detection of early signs of disease.
HealthPartners Medical Group and Clinics and The Chartis Group today announce a unique collaboration to help hospitals and health systems achieve superior performance in health care quality and patient service, while simultaneously lowering costs.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Farid Dahi, Po Box 678398, Dallas, TX 75267-8398 Ph: (800) 475-6112 | Farid Dahi, 801 Ostrum St, Bethlehem, PA 18015-1000 Ph: (484) 526-4000 |
News Archive
SurgiCount Medical, the wholly-owned operating subsidiary of Patient Safety Technologies, Inc., today announced that it has signed a contract with Kalispell Regional Medical Center to implement the SurgiCount Safety-Sponge® System, a proven solution to prevent one of the most common surgical errors, retained surgical sponges.
Since the vast majority of Americans who have health coverage get it through their jobs, one obvious question raised by the health reform legislation pending in Congress is: How might it affect the U.S. employment-based health benefits system?
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today that the Company has entered into a sponsored research agreement and an option agreement with The University of Pennsylvania to support process development and manufacturing in a planned Phase II clinical trial of ICT-107, the Company's dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme.
Young adults who were born prematurely show multiple biological signs of risks to future health, research from Imperial College London has found. The scientists, reporting their findings tomorrow in the journal Pediatric Research, say that the research indicates that urgent work is now needed to monitor preterm babies into adulthood to improve the detection of early signs of disease.
HealthPartners Medical Group and Clinics and The Chartis Group today announce a unique collaboration to help hospitals and health systems achieve superior performance in health care quality and patient service, while simultaneously lowering costs.
› Verified 6 days ago
Dr. Stuart N. Pollack, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4000 Fax: 706-653-1230 | |
Lisa M Fedullo, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 425 Brighton St, #303, Bethlehem, PA 18015 Phone: 610-868-1100 Fax: 610-868-1111 | |
Grace Fan, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Radiation Oncology Dept, Bethlehem, PA 18015 Phone: 484-526-4841 Fax: 484-526-4671 | |
Dr. Ivan Michael Fras, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 610-868-1100 Fax: 610-868-1111 | |
Dr. William W Woodruff, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 95 Highland Ave, Suite 130, Bethlehem, PA 18017 Phone: 610-868-1100 Fax: 610-868-1111 | |
William Harris Smith, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum Street, Department Of Radiation Oncology, Bethlehem, PA 18015 Phone: 845-641-9461 | |
Bassam Al-mamoori, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4000 Fax: 706-653-1230 |